{"id":531559,"date":"2021-08-26T06:03:16","date_gmt":"2021-08-26T10:03:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/"},"modified":"2021-08-26T06:03:16","modified_gmt":"2021-08-26T10:03:16","slug":"nevro-to-present-at-baird-2021-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/","title":{"rendered":"Nevro to Present at Baird 2021 Global Healthcare Conference"},"content":{"rendered":"
\n

Wednesday, September 15, 2021 at 10:50 am Eastern Time \/ 7:50 am Pacific Time<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n REDWOOD CITY, Calif.<\/span>, Aug. 26, 2021<\/span> \/PRNewswire\/ — Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. Keith Grossman<\/span>, Nevro’s Chairman, CEO and President, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021<\/span> at 10:50 am Eastern Time<\/span> \/ 7:50 am Pacific Time<\/span>.<\/p>\n

A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro’s website at www.nevro.com<\/a>.<\/p>\n

\n Internet Posting of Information<\/b>\n <\/p>\n

Nevro routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.nevro.com<\/a>.\u00a0 The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.<\/p>\n

\n About Nevro<\/b>\n <\/p>\n

Headquartered in Redwood City, California<\/span>, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. The Senza\u00ae<\/sup>\u00a0System, Senza II\u2122 System, and the Senza\u00ae<\/sup>\u00a0Omnia\u2122 System\u00a0are the only SCS systems that deliver Nevro’s proprietary 10 kHz Therapy. Senza, Senza II, Senza Omnia, HFX, HXF Coach, HFX Cloud, HFX Connect, Nevro and the Nevro logo are trademarks of Nevro Corp.<\/p>\n

To learn more about Nevro, connect with us on\u202fLinkedIn<\/a><\/u>,\u202fTwitter<\/a><\/u>,\u202fFacebook<\/a><\/u>\u202fand\u202fInstagram<\/a><\/u>.<\/p>\n

\n

\n Investors and Media:
<\/b>
\n Julie Dewey<\/span>, IRC
Nevro Corp.
Vice President, Investor Relations & Corp Communications
650-433-3247\u00a0 |\u00a0 julie.dewey@nevro.com<\/a><\/p>\n

\n

\n
\n \".\"
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/nevro-to-present-at-baird-2021-global-healthcare-conference-301360185.html<\/a><\/p>\n

SOURCE Nevro Corp.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Wednesday, September 15, 2021 at 10:50 am Eastern Time \/ 7:50 am Pacific Time PR Newswire REDWOOD CITY, Calif., Aug. 26, 2021 \/PRNewswire\/ — Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. Keith Grossman, Nevro’s Chairman, CEO and President, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 10:50 am Eastern Time \/ 7:50 am Pacific Time. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro’s website at www.nevro.com. Internet Posting of Information Nevro routinely posts information that may be important to investors in the “Investor Relations” … <\/p>\n

Continue reading “Nevro to Present at Baird 2021 Global Healthcare Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-531559","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNevro to Present at Baird 2021 Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nevro to Present at Baird 2021 Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Wednesday, September 15, 2021 at 10:50 am Eastern Time \/ 7:50 am Pacific Time PR Newswire REDWOOD CITY, Calif., Aug. 26, 2021 \/PRNewswire\/ — Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. Keith Grossman, Nevro’s Chairman, CEO and President, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 10:50 am Eastern Time \/ 7:50 am Pacific Time. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro’s website at www.nevro.com. Internet Posting of Information Nevro routinely posts information that may be important to investors in the “Investor Relations” … Continue reading "Nevro to Present at Baird 2021 Global Healthcare Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-26T10:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nevro to Present at Baird 2021 Global Healthcare Conference\",\"datePublished\":\"2021-08-26T10:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/\",\"name\":\"Nevro to Present at Baird 2021 Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\",\"datePublished\":\"2021-08-26T10:03:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-baird-2021-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nevro to Present at Baird 2021 Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nevro to Present at Baird 2021 Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Nevro to Present at Baird 2021 Global Healthcare Conference - Market Newsdesk","og_description":"Wednesday, September 15, 2021 at 10:50 am Eastern Time \/ 7:50 am Pacific Time PR Newswire REDWOOD CITY, Calif., Aug. 26, 2021 \/PRNewswire\/ — Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. Keith Grossman, Nevro’s Chairman, CEO and President, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 10:50 am Eastern Time \/ 7:50 am Pacific Time. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro’s website at www.nevro.com. Internet Posting of Information Nevro routinely posts information that may be important to investors in the “Investor Relations” … Continue reading \"Nevro to Present at Baird 2021 Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-26T10:03:16+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nevro to Present at Baird 2021 Global Healthcare Conference","datePublished":"2021-08-26T10:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/","name":"Nevro to Present at Baird 2021 Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","datePublished":"2021-08-26T10:03:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-baird-2021-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nevro to Present at Baird 2021 Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=531559"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531559\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=531559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=531559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=531559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}